Phase 1/2a Study of ANPD001 in Parkinson Disease

Abstract

This clinical trial is designed to test the safety and tolerability of injecting ANPD001 cells that will mature into dopamine-producing cells into the brain of participants with Parkinson Disease. All participants will have ANPD001 cells manufactured from their own previously collected cells. Phase: PHASE1 Status: ENROLLING_BY_INVITATION Conditions: Parkinson Disease Interventions: ANPD001; Custom Device

Keywords

Sources